

This Month | Last Month | Older
Sorry, there are currently no news items for this month
Nestlé Health Science acquires a stake in Vital Foods
Life sciences industry, universities and the NHS: new agreement launched
FLUID: changing the shape of outsourcing
Sanofi and Merck to join forces and collaborate on cancer
Novartis merges with Alcon
MEPs tighten rules on pharmaceutical companies
ABPI calls for urgent review of NICE remit
Pharmaceutical company Shire Acquires 99.21% of the shares of Movetis N.V. and Announces Commencement of Squeeze-Out Tender Period
Ablynx and Merck Serono Enter into Second Agreement To Co-Discover and Co-Develop Nanobodies®
Ophthalmology company Alcon, Names New Chief Financial Officer
NICE consults on new chronic obstructive pulmonary disease and chronic kidney disease draft quality standards
AstraZeneca announce results of Zibotentan Phase III trial in castration resistant prostate cancer
London Genetics to partner Diaceutics to Accelerate Biomarker Development in the Global Biopharmaceutical Industry
Pharmaceutical company GSK and BJD collaborate on a new educational programme
Cancer Research UK and pharmaceutical company AstraZeneca sign deal to trial first-of-kind cancer drug
Ark Therapeutics announces a major business re-structuring
Pharmaceutical company Bayer included once again in the Dow Jones Sustainability World Index
Pharmaceutical company Teva UK Limited delivers “Good health for less.”
Bristol-Myers Squibb to Acquire ZymoGenetics
Pharmaceutical company Shire Announces Commencement of Tender Offer to Acquire Movetis
Pharmaceutical company, GlaxoSmithKline pre-broadcast statement: BBC Panorama, 6 September 2010
Pharmaceutical company Gilead waits on Truvada approval .
Genzyme Confirms Receipt of Unsolicited Proposal from Sanofi-Aventis
Bayer Schering Pharma announces positive data in first single-drug approach anticoagulation therapy for DVT
Pharmaceutical company GSK European Commission amends licence for Cervarix®
Pharmaceutical company Alcon Independent Director Committee Notes Closing of Novartis' Acquisition of Nestlé's Stake in Alcon
Pharmaceutical company Inspire Announces Amendment to Ophthalmic Collaboration
111 - The New Number for Non-Emergency Health Services
Medical company Hospira announces that CEO Chris Begley is to retire
Clinical Research Organisation ClinTec International and Elephant Capital complete strategic investment deal
Medical device company Ethicon Endo-Surgery introduces new Curved Shears for extended reach in obese patients.
Pharmaceutical company Lilly Halts Development of Semagacestat for Alzheimer's Disease
Pharmaceutical company Synexus reaps the rewards of Hungary's flourishing clinical trials sector
Pharmaceutical Company Shire agrees to divest Daytrana® CII to Noven Pharmaceuticals
Pharmaceutical company Quintiles announces the addition of a Nobel Laureate to the Advisory Board
Pharmaceutical company Shire announces efficacy in Vyvanse trial.
Pharmaceutical companies Vectura and GlaxoSmithKline sign agreement to license some of Vectura’s dry powder drug formulation patents
TEMPO study further demonstrates the benefits of Azilect® in early Parkinson's disease patients
Pharmaceutical Company Shire Appoints New Human Genetics Therapy Executive
Pharmaceutical/Biotech company Almac launch Biomarkers for biopharma
Quintiles Announces New European Headquarters
AMD Appoints BK Medical as Agent for Prostate HistoScanning™ in the UK
AHF Bans BMS Drug Reps from Its Clinics
Pharmaceutical company Teva UK Limited repeats Student Bursary offer
Lilly Announces Completion of Alnara Acquisition
WHO and the IOC sign agreement to improve healthy lifestyles
How NICE could help the NHS save millions.
Pharmaceutical Companies GlaxoSmithKline, AstraZeneca and other Pharmaceutical Leaders Reduce R&D Time and Costs Using AspenTech’s Software
Pharmaceutical Company AstraZeneca and MRC Technology Form Strategic Alliance in Discovery Research, Utilising Shared Compound Libraries
Avandia stays on the market, GSK to take £1.57 billion charge
Pharmaceutical company Roche announce trial results.
Pharmaceutical company GlaxoSmithKline recognised for medicines access initiatives
Capita acquires Premier Medical Group
Health Secretary sets out future of public health
GSK funds educational programme on COPD guidelines
Digital leading the way for professional development
Pharmaceutical company Pierre Fabre recruits Abbot Pharmaceutical chief as its new CEO
Birkbeck and Southampton researchers pioneer new technology for pharmaceutical drug development
Mixed response to emergency Budget from UK industry
GW announces UK launch of world’s first prescription cannabis medicine
NICE advises against GSK's Tyverb
GSK announce submission of Benlysta to EMA
Teva Announces Positive Results From a Study Assessing a New Formulation of COPAXONE®
NICE - yes for blood cancer therapies Velcade and Thalidomide.
Greek cuts bode ill for Drugmakers
Therabel Pharma withdraws all batches of Dyloject from UK market
Royal Pharmaceutical Society of Great Britain to be replaced
Abbott recognised as one of the UK's Best Workplaces
Department of Health appoints interim CMO, while new health team takes shape
Pfizer announces 6000 job losses
Compandia announces new chairman
BaroFold Grants Exclusive License for Interferon Beta Products Developed Using PreEMT™ Technology to Nuron Biotech
Sanofi-aventis Initiates 10,000 Patient Study With Multaq(R) in Permanent Atrial Fibrillation
Abbott Laboratories in The Scientist magazine's 'Best Places to Work in Industry' list
DePuy Spine, Inc. announce the launch of EXPEDIUM®
Novartis gains new indication for Diovan®*
Abbott completes acquisition of facet biotech Abbott
Truvada® updates from Gilead Sciences, Inc
Genzyme welcomes decision on Mozobil® (plerixafor)
Medtronic, Inc. Revo MRI™ SureScan™ update
Ipsen: BIM 23A760 update
BioAlliance Pharma announce preliminary results from the first Phase I trial of fentanyl Lauriad®
Eisai Co., Ltd announce REVOVIR® update
Abbott Laboratories suspend marketing of obesity medicine Sibutramine
Abbott Laboratories announce XIENCE V® update
Update from pharmaceutical company Eli Lilly and Company
Ark Therapeutics Group plc files for re-examination of its application for Cerepro®
Merck Serono refuse to file letter from FDA on Cladribine tablets
Biotechnology company Amgen honoured at the Scrip Awards
Johnson & Johnson announce new test results for INVEGA® (paliperidone ER)
Bristol-Myers Squibb announces it will split off its holdings in Mead Johnson Nutrition Company
Global Biopharmaceutical specialty company Shire announce availability of INTUNIV™
Bristol-Myers Squibb & Alder Biopharmaceuticals Inc., announce global agreement on ALD518
Teva Pharmaceuticals seeking to amend complaint against Momenta Pharmaceuticals related to COPAXONE®
Novartis receives regulatory approval in Germany for Celtura®
Lundbeck commended for its approach to climate change
GlaxoSmithKline announce the accelerated approval of ArzerraTM (ofatumumab)
Speciality health care company Allergan announces victory in Brimonidine Patent infringement case
Genzyme Corporation announces a potential new therapy for Gaucher disease type 1
Bristol-Myers Squibb announce new clinical data supports the continued development of ORENCIA®
Pharmaceutical group Ipsen grants Menarini Group exclusive licence rights to Adenuric® (febuxostat)
Biotech company BioMimetic Therapeutics, Inc announce positive top line results
GSK announce final results for Avodart®
GSK and Walvax long term venture to develop & manufacture paediatric vaccines in China
Novartis Fluvirin® update
Pharmaceutical company GlaxoSmithKline announces top-line results for a Phase II trial
Healthcare company Abbott acquires Solvay's pharmaceuticals business
Novartis's Focetria® receives a positive opinion from the CHMP
Healthcare company Abbott top ten entry in Working Mother 100 best list
Pharmaceutical company Abbott receives FDA approval for HIV test
Bristol-Myers Squibb reaches an agreement to sell its OTC assets in Asia Pacific
Novartis publish phase III update for COPD treatment
Eli Lilly - new data for Cymbalta
GlaxoSmithKline CERVARIX® update
Pharmaceutical and healthcare company Wyeth release Enbrel® (etanercept) update
Baxter Acquires Continuous Renal Replacement Therapy Business
Bristol-Myers Squibb announce acceptance of submission for Belatacept
Abbott to collaborate with Pfizer Inc on companion diagnostic test
Bristol-Myers Squibb ORENCIA® update
Novartis receives approval in EU for Xolair®
Lilly Reports on Outcome of Phase III Study of Arzoxifene
US FDA approves Extavia® - the first in a new portfolio of planned MS therapies from Novartis
AstraZeneca & Forest Labs. to co-develop a late stage next generation anti-infective
Abbott Partners With Beech-Nut to Provide New Parents with Nutrition Education and Support
Merck Sharp & Dohme statement on FOSAMAX® (alendronate sodium)
Schering Plough gains FDA votes in favour of SAPHRIS(R) (asenapine)
Speciality Pharmaceutical company Allergan Receives FDA Approval for ACUVAIL™
Allergan Press Release: FDA Designates Fast Track Status for Apaziquone (EOquin(R)) for Bladder Cancer
Head-to-head trial demonstrates Viramune®`s similar efficacy and superior effect on lipid profile compared to atazanavir/ritonavir
WHO grants prequalification to Cervarix®: GSK’s vaccine to help combat cervical cancer in developing nations
Novartis delivers 250,000,000th Coartem® treatment and becomes first healthcare company to join United Against Malaria partnership
Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement
Novartis receives Complete Response letter from the US Food and Drug Administration for its investigational vaccine Menveo®
UCB brings Neupro® back to all patients in Europe
Boehringer Ingelheim receives positive recommendation from European scientific committee for a new once daily Mirapexin®
Jazz Pharmaceuticals and UCB announce second Phase III study of sodium oxybate in patients with fibromyalgia meets primary endpoints
NUCYNTA™ (tapentadol) CII Immediate Release Tablets Now Available for Relief of Moderate to Severe Acute Pain
Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
Johnson & Johnson Announces Regulatory Clearance for its planned acquisition of Cougar Biotechnology
Allergan Receives FDA Approval for OZURDEX™
Pharmaceutical group Ipsen & Pharma company Galderma Azzalure® Press Release
Boehringer Ingelheim and Vitae Pharmaceuticals announce Alzheimer's disease collaboration
Pharma company GSK announce strategic alliance with Dr Reddy's
ORENCIA® (abatacept) demonstrates consistent safety and effectiveness over 7 years
Lilly resubmits Cymbalta Supplemental New Drug Application for Chronic Pain to U.S Food & Drug Administration
Pharma company Pfizer introduces new treatment & support plan for patients with Overactive Bladder
Pharma company Pfizer update: Two other phase 3 advanced breast cancer trials of Sunitinub continue
Bristol-Myers Squibb Press Release: FDA Grants Full Approval for SPRYCEL®
Pharma company Lilly advances second Alzheimer's disease treatment
Pharma company Pfizer expands its Generics Portfolio
Lundbeck provides update on NDA for Serdolect® for the treatment of schizophrenia
Pharma company GSK update: A (H1N1) influenza vaccine development
Healthcare company Abbott ARCHITECT® i 2000 and i 2000SR Update
Pharma company Novartis receives approval from FDA to market Prevacid®
Pharma company GSK extend strategic collaboration with Aspen
Pharmaceutical companies Amylin Pharmaceuticals, Inc & Eli Lilly & Company have agreed joint device supply
Biogen Idec AVONEX - first ten year follow up
Healthcare & Nutrition company Nestle team up with Marie Curie Cancer Care
Pharmaceutical company Boehringer Ingelheim - Press Release
Pharmaceutical company Merck & Co,. Inc. publish Interim Phase IIa study results
DRAGON JAMES CAAN INVESTS IN RISING CONTRACT SALES ORGANISATION STAR
Pharma company GlaxoSmithKline launch clinically proven weight loss aid
Pharma company GlaxoSmithKline create specialist dermatology business
Healthcare Company Abbott Laboratories announce financial results for first quarter
Sanofi-aventis to acquire US biopharmaceutical company BiPar Sciences
H. Lundbeck A/S progress for schizophrenia drug
Bayer Schering, the prescription medicines arm of Bayer Healthcare in the UK) press release
Bayer Healthcare AG Update - Bayer's Rivaroxaban receives favourable profile
Pharmaceutical company GlaxoSmithKline plc publishes corporate responsibility report 2008
Ethical pharmaceutical company Servier work alongside NICE on osteoporosis guidance
Merck & Co., Inc. and Medicines for Malaria licensing agreement
Pharmaceutical company Pfizer Inc, BRIDGE survey press release
Pharmaceutical Company Sanofi-aventis: Press Release
Biotech company Merck & Co to merge with Schering Plough
Biopharmaceutical company Bristol-Myers Squibb enters global collaboration
Pharmaceutical company Pfizer & Bosch & Lomb announce a collaboration
Healthcare company AstraZeneca's Seroquel XR update
STAR News - Pfizer Inc Press Release
Abbott tender for common stock of Advanced Medical Optics
Abbott's Abbott Fund Press Release
Healthcare company Roche takes a step forward in the treatment of hepatitis B
Vaccines company Sanofi Pasteur sponsors phase II vaccine trial
Merck & Co., Inc. acquires biologics capability from Insmed
Grunenthal Ltd addition to pain management portfolio
AstraZeneca’s Partner, POZEN’s FDA update
Lundbeck to acquire Ovation Pharmaceuticals Inc
Positive results for Pfizer's Intensive Lipitor therapy
GlaxoSmithKline announces changes to the board
Lundbeck Foundation News
ImClone Systems and Bristol-Myers Squibb Update the Status of Non-Small Cell Lung Cancer Supplemental Biologics Application Submission for ERBITUX®
New Biologic receives European approval for moderate to severe Psoriasis
Wyeth treatment approval for psoriasis therapy in children
Eli Lilly settle Zyprexa probe
FDA approves once-yearly treatment for osteoporosis in men
New Pharmaceutical Research Laboratory for Abbott
Roche, Genentech and Merck tipped for growth in URCH market research
Medical and Surgical Equipment Company receives Award
Abbott Molecular Update
Merck Serono statement regarding Singulair
Lilly's Olanzapine LAI for treatment for Schizophrenia in Adults
Bayer Schering Pharma exclusive option for collaboration
NITEC Pharma Rheumatoid Arthritis Treatment Update
GlaxoSmithKline News
Acacia Pharma completes clinical trial for nausea and vomiting
Merck Serono - treatment for KRAS wild-type tumours
Lundbeck bipolar disorder treatment moves to phase II
GSK and Xenoport Press Release 10th November 2008
AstraZeneca's CRESTOR success in Large Statins Outcomes Study
Tarveca brings new hope for non-small cell lung cancer
ProStrakan US launch 6th November 2008
Genzyme and Osiris Partner 5th November 2008
Nationwide Key Account Executive build!
New developments for Pfizer's TOVIAZ 4th November 2008
Promising growth for Novo Nordisk
Solid growth at Bayer Healthcare
AstraZeneca event in Spain a forum to discuss Bipolar disorder research
Novartis treatment shows significant progress as a treatment for CAPS
GlaxoSmithKline to acquire the leading dry mouth brand, Biotene
Boehringer Ingelheim's pipeline update unveils novel investigational compounds heralding the company's entry in to Type 2 Diabetes
NICE chairman suggests a new way of thinking about clinical research
Lilly expands R&D activity to Singapore's Biopolis
GSK acquisition of Bristol-Myers Squibb's off patent product business in Egypt
GSK Responds to NICE's second technology appraisal consultation document on the use of Tyverb, in combination with Capecitabine...CONTINUED...
GSK Responds to NICE's second technology appraisal consultation document on the use of Tyverb, in combination with Capecitabine
Lilly Recognised as one of the world's top biopharmaceutical employers
SCOLR Pharma Announces completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen
Pharmaceuticals: Near Term Movers Based On FDA Decision Dates
US Food & Drug Administration approved the use of REYATAZ boosted with Ritonavir in combination therapy, for previously untreated HIV-1 Infected Adult Patients
Bayer sets up oncology pact in Singapore
Link discovered between poor sleep and obesity
Problem discovered with aloe vera
Switzerland-headquartered Nycomed has announced plans to cut over 250 jobs in a bid to improve the competitiveness of its manufacturing network in Europe.
Boehringer leaps to the defence of Spiriva over cardiovascular risk claim
Statins shown to have to have other vital medical uses
UK has a massive 950 products in pipeline
Infections linked to Cot Death
Hospitals are down to their last line of defence against Superbugs.
Liberal Democrats give support to “top up” payments for cancer drugs.
AstraZeneca and Targacept announce top-line results from Phase llb Study of AZD3480 in Alzheimer's disease
CV Therapeutics signs $385 million Ranexa deal with Menarini
Osprey raises $11 million in private financing
Pfizer Press Release: Pfizer Animal Health Adds Former Schering-Plough Products to European Portfolio
Experts concerned about the increasing resistence of certain bugs to antibiotics
Exciting developments for Novo Nordisk...
Interesting time ahead for the biggest pharmaceutical companies in the industry
Researchers urge patients to continue with Inegy despite latest study
Research demonstrates the increased use of Diazepam on the street
Study reveals a positive reflection of hip and knee surgery in the UK
Link between antipsychotic drugs and stroke incidents confirmed by research
Azilect, manufactured by Teva, has performed well in Parkinson's trials
NICE/Novartis agreement gives new hope to Wet ARMD patients
Effective treatment for diabetes type 1 set for further clinical testing
Immune boosting drug may also be a suitable treatment for Non-Hodgkin's Lymphoma
Innovative new method of detecting skin cancer has proved successful in a recent study
Trials underway for new injection to treat rheumatoid arthritis
New study reveals that a new combination of drugs could effectively treat breast cancer
Clamelle, the first antibiotic to be sold over the counter, is introduced to tackle soaring Chlamydia rates
Study suggests that vitamin C may help in the fight against cancer
Changes to guidance surrounding co-proxamol worry patients...
New evidence highlights the immune system's ability to tackle Alzheimer's
New research suggests the IVF technique is not the cause of pregnancy complications
A new study suggests that statins used to lower cholesterol may benefits those at risk of dementia
Effective drugs have increased the life expectancy of HIV sufferers
Abiraterone acclaimed as the most significant medical advance in 70 years
New NICE guidelines for rheumatoid arthritis treatment cause concern amongst campaigners
Hayfever treatment may provide a new solution for Alzheimer's patients
Good or bad? Variable Ritalin use exposed by latest statistics...
Interesting results which may shed light on the effect of a mother's weight on future generations...
Enzyme may provide a faster, more effective therapy for neurological patients
Controversial procedure provides interesting results for retinitis pigmentosa patients
MS sufferers failed by the NHS
High blood pressure increases risk of dementia.
Government pledges spend on Cognitive Behavioural Therapy despite a negative response...
Deadly form of malaria on the increase in the UK
New links between users of potent cannabis and psychosis
Development in IVF testing may provide a greater insight for patients
New test to provide hope for multidrug-resistant Tuberculosis patients in developing countries
Prenatal benefits of Mediterranean diet
Scepticism over NICE decision to allow Acomplia to be prescribed on the NHS
New gene test may enable doctors to pin-point those at risk of breast cancer sooner
Warning: this tablet contains nothing at all.
Children to teach parents about 5-a-day
Clincal trial reports potential new treatment for skin cancer
Cholesterol lowering statins may be instrumental in minimising the risk of emergency caesarean procedures.
Scientists pledge to tackle unknown viruses
New research demonstrates a link between CETP gene and a decreased risk of heart disease
Study reveals GPs still prescribing anti-psychotic medication to elderly dementia patients despite government guidelines
Surgical robot to revolutionise hip and knee replacement surgery
New drug provides renewed hope for migraine sufferers
Chemical composition of genes may provide clue to cancer risk
New study suggests the immune system can be used to help fight Alzheimer's disease
Scientists find possible link between cot death and common bacteria
Gum disease linked to cancer risk
Medicinal hot chocolate for diabetes patients.
Super drug for Super bug.
"A Sickle Crisis?"
MPs vote to keep 24 week abortion limit.
GSK bird flu vaccine victory.
Measles is “still spreading”.
Human Fertilisation and Embryology Bill to be voted on this week.
The rising cost of obesity.
Viagra hope for muscular dystrophy patients
Government's health screening plans meets with scepticism
Will Britain introduce compulsory vaccinations?
Possible genetic link to pre-eclampsia.
Ibuprofen may help protect against Alzheimer's
Osteoporosis drug increases risk of heart condition
Eisai Victory.
Norton pays out £2.8 million to Scottish Government.
HTA regulations for collection of cord blood.
Clinical trial for high-street anti-ageing cream
Widely used cancer drug linked to brain damage side effects
London hospital fits revolutionary new 'eye' to blind man
Government report proves efficacy of vaccines.
Boehringer Ingelheim’s Pradaxa welcomed by experts.
Renewed concerns over the safety of vitamin supplements.
Ketogenic diet can be more effective than drugs for childhood epilepsy
Dust mite reduction equipment - a waste of money?
Eisai take NICE ruling to Court of Appeal.
Possible link between pollution and pneumonia.
The HGH black market.
GW Pharmaceutical suffers decrease in share prices
Concerns over premature conclusions of drug trials
Depression linked to Alzheimer’s disease.
Increase in number of British kids on anti-psychotic medication.
New study finds GSK anti-HIV drug increases risk of heart disease.
Paracetamol and liquids by far the best treatment for childhood colds
Novartis sight-saving medicine to be recommended by NICE
Fresh TB research findings may lead the way to new treatments.
Concern at ‘over-prescription’ of anti-psychotic drugs.
MRI scans risk false positives.
Possible deregulation of laser treatments
HRT must be used in early stages of menopause to maximise efficacy.
Labour MPs to vote freely on key embryo bill clauses.
Drug trial safety monitoring fear.
Phantom heads prepare dental students for an early start
Possible new gene therapy to treat rare brain-wasting condition
Natural protein provides blindness cure clue
Womb conditions can affect future fertility.
No evidence for links between deodrants and breast cancer
Postcode lottery for prostate cancer care
No smoking day – Weds 12th March.
Gout risk could be in the genes.
Low testosterone levels linked to depression in older men.
New in-store GP services
Fresh research raises hopes for obesity drugs
New genetic marker may help in fight against breast cancer.
GSK’s Lapdap withdrawn.
A good year for Ipsen.
Teenagers to be offered nicotine replacement therapies
Antidepressants not much more effective than a placebo
New IVF technique to be trialled in the UK
Viagra may damage fertility
First-ever palliative care strategy for children in England.
Healthy Sperm is needed for healthy children
Kidney drug to help fight against malaria
Daily exercise is essential for keeping weight off after dieting.
Pharmacists and public urged to use Yellow Card Scheme.
Conflicting results over intensive glucose control.
NHS to carry out pioneering cell transplants on diabetes patients
Increased drinking amongst successful men
Genetically modified viruses can kill pain
British surgeons to repair hearts with stem cell injections
Work stress linked to heart attack risk
Controversial DNA Website comes to UK
Earthquakes provide clues for epilepsy prevention
“Presumed consent” for organ donation
Beating heart grown in laboratory
Norovirus reaches epidemic proportions
A little alcohol + active lifestyle = longer life
Commons call for drug decisions to be made faster
Better health and IQs for breastfed babies
Lack of sleep can lead to obesity
New pacemaker prevents fainting
Cosmetic clinics underplay surgery risks
New screening programme for at risk patients
New indications for aloe vera
City-dwellers are more at risk of breast cancer
Our neglected dementia patients
Thought-controlled bionic limb now has sense of touch
Cooling treatment can prevent brain damage
Dirty ambulances may be contributing to MRSA problem
Break-through in gene-based therapy for Parkinson’s
UK sees increase in Hepatitis B
Migraine is a brain disorder
The power of HIFU bubbles
Atkins diet harmful to blood vessels
Should the obese be barred from fertility treatment?
Still more restrictions needed on junk food adverts
Threat of cancer link with contraceptive pill is “reversible”
BBC programme says “Drugs for ADHD are not the answer"
Hypertension is worse in the winter
Obesity impacts on cancer in women
Government accused of “dragging their feet” on artery screening programme.
Significant new epilepsy findings
Job cuts at GlaxoSmithKline
General support for practice-based commissioning marred by despondency at implementation failures
PDCO product waivers for Novartis, AstraZeneca and Takeda Pharmaceutical
Development of Bone Cement for spinal injuries
Fewer female sterilisations being carried out in England
Genetics may influence what we eat, recent studies show
Hospital bugs have been blamed on poor leadership within the NHS
Recent success in IVF alternative provides new choices for infertile women in the UK
Appeal against NICE rationing of osteoporosis drugs.
Increase in injuries caused by Medtronic implantable heart device wires
Controversy over plans to store stem cells made from IVF embryos
New reports on the efficacy of acupuncture in IVF & post-surgical pain
Chlamydia threatens both male and female fertility
60% of UK cot deaths could be avoided
A weekly household clean can increase the risk of developing asthma
Many hospital patients do not speak out about poor care in hospitals
A device developed for space exploration could provide new solutions to TB diagnosis and prevention
Innovative new drug may prove to be a breakthrough in the treatment of child cancer
Is the NHS wasting money on bath emollients?
Government to ban doctors’ white coats
Perceived food intolerances may cause long term health risks
New advance in keyhole heart surgery
Excessive prescriptions for expensive antibiotics
Oral treatment for type 1 diabetes possible
Reports of serious drug events double in the U.S.
New jet injection to improve skin cancer treatment
Decline in use of SSRIs correlates to increased suicide risk
Contraceptive pill cuts overall risk of women developing cancer
Naturally occurring anti-cancer treatment found in tangerines
New Schizophrenia Medication shows promising early results
UK Clinics to offer egg freezing
GPs ignoring child asthma advice
Conservative party would match Labour’s projected public spending
The developing world needs more money to spend on mental health
Sutent available for free in clinical trial in Manchester
Which? Study shows "flawed" eye tests
Warning over lack of Out of hours care
Former smokers are still at greater risk of lung cancer
Blood chemicals link to eczema discovered
Closure of Four Maternity Units in Greater Manchester
Experts warn that many teenagers are surviving on ‘Junk Sleep’
UK “lagging” on cancer survival
Healthy eating trend boosts brands
GPs profiting from client records
Internet pharmacies a risk to your health
Estimate of 1.56 billion adults having high blood pressure by 2025
Unhappiness is too often being mistaken for Depression
Progen product may be granted Orphan Drug status
South Walian leeches save Isle of Dogs leg!
Coffee danger!
HIV attacks brain cells twice!
More accurate aid to diagnosis of infection in prosthetic joints discovered
Fat around the waist is more dangerous than fat on the hips!
Oral antidiabetic drug market to flourish
New urine test to improve accuracy of obesity studies
Bacteria-eating virus is possible solution to MRSA problem
Elderly people being “let down” by poor mental health provision
Novartis product Prexige is withdrawn from the Australian market
Electrodes rouse man in coma-like state
Call for Donor Children to have status put on Birth Certificate
Nurse shortage is affecting Mental Health Care
UK being treated as “Guinea pigs” for cosmetic surgery
First Successful Ovarian Transplant between non identical sisters performed
Bristol - Myers Squibb’s “Orencia” Blocked for NHS Use
Statin link to cancer
Department of Health unveils new team
Evista backed by FDA for breast cancer
Health Secretary unveils new drive to improve access to GP services
National Health Service Review
Chief medical officer promotes clean hands
DH names oversight group for pharmacy royal college
Generic drug market to double
Boots puts new management team in place
FDA warns of internet pharmacies
Calls for flu anti-virals to made available over the counter
AstraZeneca delays new drug distribution plans
Young face 'hearing loss timebomb'
Johnson new health minister
GPS to screen all patients for heart disease
Insulin pill developed
NHS to fight climate change
Investors highlight challenges for pharmaceutical industry
NHS Ritalin bill hits £1 million a month
Authorised generics used to cut losses
Glaxo consumer healthcare sell-off mooted
World pharmaceutical sales to hit $1.3 trillion
UK DNA study breakthrough discovers disease genes
Superbugs become more resistant
Abbott diabetes device gains CE mark
Police investigate counterfeit parallels
Reach may impact on pharmaceutical industry
European ministers agree on tissue engineering
NICE recommends anti-smoking drug
Value-based pricing may up drug spend
Counterfeit drugs found in UK
'One-two punch' cure for hep C
NICE offers new child fever advice
Digital x-rays to go nationwide in 2008
iPod risk for pacemakers
New properties for statins
UK travellers fail to use malaria medication
NHS could save £300m through better prescribing
New drug class to wake up insomnia sales
Pharmacists set for new regulator
DoH puts heatwave plans in place
Europe aims to bring in faster access to new medicines
Cancer tsar: NHS must change
Cardiovascular disease to be world's biggest killer
UK failing for new cancer drug access
Hay fever treatment demands rises
Flu pandemic vaccine given clearance
Antibiotics market to be worth $25bn
BMA calls for NHS constitution
Healthcare to face shake up from climate change
Maggots and honey in hospitals to treat superbugs
Governments 'must act on diabetes'
Generic biologics 'unlikely to give significant savings'
UK has 950 drugs in the pipeline
Public urged to report faulty medical equipment
Hospital infection rates rise
Flu medicines used to create crystal meth
Biotech prescribing set to rise
Competition and the dollar stymie Glaxo profit
World's first 360º MRI scanner in Oxford
Nano wound care unveiled
Global pharmaceutical sales increase
Location: London and the South West
Salary: Salary £25,000 - £30,000
Notes: <p>Nurse Advisor</p> <p>London and the South West</p> <p>Salary £25,000 - £30,000 plus benefits</p> <p>Permanent position</p> <p>1201 -130</p> <p>Star's searching for a talented Nurse Advisor with experience in tissue viability on behalf of a <strong>market leading supplier of specialist equipment to the NHS, community and nursing home sectors.</strong><strong> </strong>This is a fantastic opportunity to be your own boss and work under your own initiative!</p> <p>You'll be responsible for contributing to the development and provision of a high quality nursing service and to function as part of the team by providing clinical support. It's essential you have an up to date pin with an ENB998 or City and Guilds 930 teaching course.</p> <p>So if you're passionate about your work and would like more information about this exciting opportunity, contact Kevin at Star today on 01628 581 240 or email your CV to <a href="mailto:kevin.osullivan@starmedical.co.uk">kevin.osullivan@starmedical.co.uk</a> to apply.</p>
Location: Leeds, Airedale, Barnsley, Calderdale and Huddersfield
Salary: Competitive salary and benefits
Notes: <p>Key Account Manager - Rheumatology</p> <p>Leeds, Airedale, Barnsley, Calderdale and Huddersfield</p> <p>Competitive salary and excellent benefits</p> <p>Contract position</p> <p>1111-108</p> <p>Star's recruiting for a new and exciting Key Account Manager opportunity on behalf of a market leading biopharmaceutical company; our client is devoted to creating innovative medical products to improve human health around the world, and offers excellent career development opportunities, recognition and rewards!</p> <p>It'll be your job to build long-term relationships with key customers in the Rheumatology community; you'll have expert knowledge of the NHS environment and its initiatives, and the ability to influence key connections to achieve sales objectives.</p> <p>We'd like to hear from enthusiastic people with the drive and determination to succeed. Confident, proactive and diligent in your approach, you'll maintain focus under pressure and ideally have previous experience in the haematology or oncology markets.</p> <p>So if you're experienced in a dedicated hospital sales role, and would like further information on this Key Account Manager opportunity, please contact Sam at Star on 01628 581240 or email your CV to <a href="mailto:samantha.wise@starmedical.co.uk">samantha.wise@starmedical.co.uk</a></p>
Location: Nationwide opportunity
Salary: Competitive salary and benefits
Notes: <p>Head of Key Accounts</p> <p>Nationwide opportunity</p> <p>Competitive salary and excellent benefits</p> <p>Permanent position</p> <p>1201-126</p> <p>Star's searching for a resilient, hard-working and proactive achiever to join a market leader in ophthalmology in a role with a fantastic salary and benefits package!</p> <p>It will be your job to lead the key account team in the UK and Ireland and deliver sales plans for key accounts; you'll work closely with heads of departments to support the field sales team and provide accurate sales, investment and demand forecasts when needed.</p> <p>People with excellent team working and communication skills and the ability to work under pressure will thrive in this management role. You must have proven sales leadership and people management skills, extensive knowledge and experience of the sales function including relevant chain, channel and category management and a pragmatic and decisive approach to your work.</p> <p>So if have the ability to manage tactically and a strong understanding of the market then we'd like to hear from you! Contact Mike at Star today on 01628 581 240 or email <a href="mailto:michael.kan@starmedical.co.uk">michael.kan@starmedical.co.uk</a></p>
Location: East of England
Salary: Negotiable salary depending on experience
Notes: <p>Medical Liaison Manager</p> <p>East of England</p> <p>Negotiable salary depending on experience</p> <p>Permanent position</p> <p>1201-62</p> <p>Star's recruiting for an accomplished Medical Liaison Manager to join a 'boutique' pharmaceutical company renowned for its great team culture; our client maintains a 'small company' ethos which allows its employees to capitalise on market opportunities!</p> <p>To be successful in this role you must have experience of selling to payers and KOLs as well as previous experience in a strategic NHS role. An in depth understanding of the NHS environment and NHS policy at national and local level is essential, along with demonstrable key account management, proven business acumen, networking skills and strong project management experience.</p> <p>If you'd like to find out more about this Medical Liaison Manager opportunity, please call Michael at Star on 01628 581 240 or email your CV to <a href="mailto:michael.kan@starmedical.co.uk">michael.kan@starmedical.co.uk</a></p> <p> </p>
Location: Dublin
Salary: Salary up to £45,000
Notes: <p>Business Sales Executive</p> <p>Dublin</p> <p>Salary up to £45,000 with the potential for £20,000 bonus</p> <p>Permanent position</p> <p>1112-70</p> <p>Star's recruiting for a driven and proactive self-starter with good market awareness to join a leading provider of sales, marketing, and distribution solutions to the healthcare sector in Ireland and the UK; our client is dedicated to quality and boasts a strong product pipeline for the months ahead!</p> <p>It will be your job to sell the clinical benefits of our client's products through sales presentations, and raise awareness of them as a market leader in the UK and Ireland; you will work hard to establish and maintain high quality partnership relationships with KOLs, Clinical and Nursing Consultants, and Purchasing Managers to create new business sales.</p> <p>People with sales experience in the healthcare industry, ideally in the laboratory market will thrive in this sales-focused role! Applicants must have a third level qualification in a scientific field and expertise within the area of life sciences and molecular pathology.</p> <p>So if you have excellent communication skills and the ability to develop long-term business opportunities, we'd like to hear from you! To find out more about this exciting opportunity, please contact Kevin at Star on 01628 581 240 or email kevin.o'sullivan@starmedical.co.uk</p>
Location: Chesterfield
Salary: Negotiable salary
Notes: <p>Master Data Clerk UK</p> <p>Chesterfield</p> <p>Negotiable salary based on experience</p> <p>Permanent position</p> <p>1201-77</p> <p>A brand new opportunity has arisen for an organised, analytical person competent in the use of excel to join a rapidly growing company that supplies medical and surgical products directly to Hospitals; this position offers fantastic career prospects and scope for promotion!</p> <p>Your role will focus on margin management and the upkeep of the master data file using existing programs and your accuracy and proficient analytical skills; you will cleanse and maintain master data, including customer and supplier contract libraries, and highlight margin issues on a daily basis. </p> <p>The successful candidate will be able to demonstrate experience in a similar role, preferably within a fast moving, high volume environment, and experience of product management. You must be detailed orientated, have first-class problem solving skills and the ability to manage high volume data!</p> <p>So if you have a clear focus on quality and would like to find out more, please contact Kevin at Star on 016281 581 240 or email <a href="mailto:kevin.osullivan@starmedical.co.uk">kevin.osullivan@starmedical.co.uk</a></p> <p> </p>
Location: Buckinghamshire
Salary: Salary £32-37K
Notes: <p>Senior Medical Writing Associate</p> <p>Buckinghamshire</p> <p>Salary £32-37K plus benefits and bonus</p> <p>Permanent position</p> <p>1112-121</p> <p>Star's recruiting for a Medical Writer to join one of the top pharma companies in the UK! You will author or assist with the authoring of regulatory documents for clinical research, including clinical study reports, clinical summary sections of common technical documents, investigator brochures and protocols.</p> <p>The ideal applicant will be an experienced Medical Writer with experience of medical writing within the pharmaceutical or CRO industry. You must be detail orientated, have a PHD, Maters or Degree in Life Sciences or Biological Sciences and familiarity of clinical trial processes.</p> <p>To apply or for more information please contact Andy Smith at Star on 01635 40755 or email your CV to <a href="mailto:andy.smith@starmedical.co.uk">andy.smith@starmedical.co.uk</a></p> <p> </p>
Location: Berkshire
Salary: Competitive salary plus benefits
Notes: <p>Clinical Project Manager</p> <p>Berkshire</p> <p> </p> <p>Competitive salary plus benefits</p> <p>Permanent position</p> <p>1201-79</p> <p>We're searching for an experienced and motivated Clinical Project Manager to work on international clinical trials! This is an office based Project Manager role based in Berkshire, although 2 days a week from home is feasible.</p> <p>You'll be responsible for managing all aspects of assigned clinical trials, including study preparations, site initiations, periodic monitoring, status and safety reporting; you'll be working on a range of studies so no precise therapeutic experience is needed providing you have project management experience at a UK CRO.</p> <p>So if you're educated to degree standard and have experience managing multi-national studies as a Clinical Project Manager then we'd like to hear from you! Contact Andy at Star on 01635 40755 or email <a href="mailto:andy.smith@starmedical.co.uk">andy.smith@starmedical.co.uk</a> to find out more.</p>
Location: North East
Salary: Negotiable salary plus excellent benefits
Notes: <p>Product Specialist</p> <p>North East</p> <p>Negotiable salary plus excellent benefits</p> <p>Permanent position</p> <p>1201-149</p> <p>A new opportunity has arisen for someone with knowledge of capital equipment sales to join a leader in cardiac and neurological device technology; you'll have the opportunity to develop and progress your career with our client!</p> <p>Providing technical support and assistance to the sales force and physicians will be your main priority; you'll make sure that you maintain up-to-date technical knowledge of new therapies and technologies as well as a general understanding the country healthcare market.</p> <p>Star would like to speak to influential individuals with knowledge of cardiac catheter lab and operating room procedures and protocol. Ideally you will have experience with programmable medical devices and software based medical systems; strong communication skills, both verbal and written are essential to this role.</p> <p>To apply or to find out more about this Product Specialist opportunity, contact Rosie at Star today on 01628 581 240 or email your CV to <a href="mailto:rosie.kausar@starmedical.co.uk">rosie.kausar@starmedical.co.uk</a></p>
Location: Birmingham
Salary: Salary up to £35,000
Notes: <p>Territory Manager - Diabetes Device</p> <p>Birmingham</p> <p>Salary up to £35,000 plus attractive bonus structure</p> <p>Contract position maternity cover</p> <p>1201-45</p> <p>Star's recruiting for a proactive, dedicated individual with medical sales experience to enter into a fast and expansive commercial market with a company committed to improving the quality of life for people with diabetes; you will work with nurses and consultants in the diabetes field as a Territory Manager and be responsible for an account management style of working within primary and secondary care. You'll drive to achieve annual sales targets and increase market share through building influential relationships with key diabetes personnel.</p> <p>We'd like to speak to enthusiastic, driven and versatile achievers with good demonstrable sales figures to date and the ability to effectively manage key accounts within primary or secondary care; diabetes experience is also desirable in this role.</p> <p>So if you have a pragmatic approach to problem-solving, and would like further information on this exciting opportunity, please contact John at Star on 07590182753 or email your CV to <a title="mailto:john.turnbull@starmedical.co.uk" href="mailto:john.turnbull@starmedical.co.uk">john.turnbull@starmedical.co.uk</a></p>